Mostrar el registro sencillo del ítem

dc.contributor.author
Silva, Márcia B.  
dc.contributor.author
Schattner, Mirta Ana  
dc.contributor.author
Ramos, Celso R. R.  
dc.contributor.author
Junqueira de Azevedo, Inácio L. M.  
dc.contributor.author
Guarnieri, Míriam C.  
dc.contributor.author
Lazzari, María Ángela  
dc.contributor.author
Sampaio, Claudio A. M.  
dc.contributor.author
Pozner, Roberto Gabriel  
dc.contributor.author
Ventura, Janaina S.  
dc.contributor.author
Ho, Paulo L.  
dc.contributor.author
Chudzinski Tavassi, Ana M.  
dc.date.available
2018-08-14T00:30:03Z  
dc.date.issued
2003-01  
dc.identifier.citation
Silva, Márcia B.; Schattner, Mirta Ana; Ramos, Celso R. R.; Junqueira de Azevedo, Inácio L. M.; Guarnieri, Míriam C.; et al.; A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning; Portland Press; Biochemical Journal; 369; 1-2003; 129-139  
dc.identifier.issn
0264-6021  
dc.identifier.uri
http://hdl.handle.net/11336/55306  
dc.description.abstract
A novel prothrombin activator enzyme, which we have named 'berythractivase', was isolated from Bothrops erythromelas (jararaca-da-seca) snake venom. Berythractivase was purified by a single cation-exchange-chromatography step on a Resource S (Amersham Biosciences) column. The overall purification (31-fold) indicates that berythractivase comprises about 5% of the crude venom. It is a single-chain protein with a molecular mass of 78 kDa. SDS/PAGE of prothrombin after activation by berythractivase showed fragment patterns similar to those generated by group A prothrombin activators, which convert prothrombin into meizothrombin, independent of the prothrombinase complex. Chelating agents, such as EDTA and o-phenanthroline, rapidly inhibited the enzymic activity of berythractivase, like a typical metalloproteinase. Human fibrinogen Aα-chain was slowly digested only after longer incubation with berythractivase, and no effect on the β- or γ-chains was observed. Berythractivase was also capable of triggering endothelial proinfiammatory and procoagulant cell responses, von Willebrand factor was released, and the surface expression of both intracellular adhesion molecule-1 and E-selectin was up-regulated by berythractivase in cultured human umbilical-vein endothelial cells. The complete berythractivase cDNA was cloned from a B. erythromelas venom-gland cDNA library. The cDNA sequence possesses 2330 bp and encodes a preproprotein with significant sequence similarity to many other mature metalloproteinases reported from snake venoms. Berythractivase contains metalloproteinase, desintegrin-like and cysteine-rich domains. However, berythractivase did not elicit any haemorrhagic response. These results show that, although the primary structure of berythractivase is related to that of snake-venom haemorrhagic metalloproteinases and functionally similar to group A prothrombin activators, it is a prothrombin activator devoid of haemorrhagic activity. This is a feature not observed for most of the snake venom metalloproteinases, including the group A prothrombin activators.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Portland Press  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Endothelium  
dc.subject
Enzyme Activator  
dc.subject
Fibrinogen  
dc.subject
Cell Adhesion Molecules/Drug Effects  
dc.subject
Von Willebrand Factor  
dc.subject
Berythractivase  
dc.subject
Coagulation  
dc.subject
Thrombosis  
dc.subject.classification
Hematología  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-08-08T14:49:24Z  
dc.identifier.eissn
1470-8728  
dc.journal.volume
369  
dc.journal.pagination
129-139  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Silva, Márcia B.. Universidade Federal de Pernambuco; Brasil. Governo do Estado de Sao Paulo. Secretaria da Saude. Instituto Butantan; Brasil  
dc.description.fil
Fil: Schattner, Mirta Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Ramos, Celso R. R.. Governo do Estado de Sao Paulo. Secretaria da Saude. Instituto Butantan; Brasil  
dc.description.fil
Fil: Junqueira de Azevedo, Inácio L. M.. Governo do Estado de Sao Paulo. Secretaria da Saude. Instituto Butantan; Brasil  
dc.description.fil
Fil: Guarnieri, Míriam C.. Universidade Federal de Pernambuco; Brasil  
dc.description.fil
Fil: Lazzari, María Ángela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Sampaio, Claudio A. M.. Universidade Federal de Sao Paulo;  
dc.description.fil
Fil: Pozner, Roberto Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Ventura, Janaina S.. Governo do Estado de Sao Paulo. Secretaria da Saude. Instituto Butantan; Brasil  
dc.description.fil
Fil: Ho, Paulo L.. Governo do Estado de Sao Paulo. Secretaria da Saude. Instituto Butantan; Brasil  
dc.description.fil
Fil: Chudzinski Tavassi, Ana M.. Governo do Estado de Sao Paulo. Secretaria da Saude. Instituto Butantan; Brasil  
dc.journal.title
Biochemical Journal  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1042/BJ20020449